Cargando…
The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome
Autores principales: | Mc Guire, C, Rahman, M, Schwaninger, M, Beyaert, R, van Loo, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613833/ https://www.ncbi.nlm.nih.gov/pubmed/23470538 http://dx.doi.org/10.1038/cddis.2013.55 |
Ejemplares similares
-
NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20
por: Drennan, Michael B., et al.
Publicado: (2016) -
A20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection
por: Maelfait, Jonathan, et al.
Publicado: (2012) -
Correction: A20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection
por: Maelfait, Jonathan, et al.
Publicado: (2012) -
Advances in the Study of the Ubiquitin-Editing Enzyme A20
por: Bai, Wenya, et al.
Publicado: (2022) -
A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme
por: Malynn, Barbara A., et al.
Publicado: (2009)